Psychiatric Genotype/Phenotype Project Repository

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt University
Study ID
NCT00762866
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - 65 Years
Healthy Volunteers
Accepted

Study Details

The purpose of this project is to obtain DNA, brain imaging data, other biological samples (e.g., urine, serum), and a comprehensive clinical assessment on patients with schizophrenia and other psychotic disorders, bipolar disorder, major depression, and normal volunteer controls. Understanding the physical and genetic factors related to these disorders will help us make progress in fitting treatments to an individual's needs. Participants will take part in a detailed clinical assessment, two blood draws, and an MRI scan over two visits. Participants will also be asked to provide urine and saliva samples.

Key Dates

Start date
Sep 30, 2008
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: MDD
    Unipolar Major Depressive Disorder, any subtype
  • Arm: Bipolar
    Bipolar I or II Disorder or Bipolar Disorder NOS
  • Arm: Psychosis
    Psychotic Disorder including Schizophrenia, Schizoaffective, Schizophreniform, Brief Psychotic Disorder, and Psychotic Disorder NOS

Primary Outcome Measure

Brain volume [ Time Frame: 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbilt University Medical CenterNashvilleTennessee37212-

Find similar trials in Nashville, TN

By condition
Bipolar disorderDepression
By specialty
PsychiatryMental healthBehavioral health
By research site
Vanderbilt University Medical Center· Nashville, TN

Related Studies